Bellus Financial Statements From 2010 to 2022

BLU
 Stock
  

USD 8.32  0.22  2.72%   

Bellus Health financial statements provide useful quarterly and yearly information to potential Bellus Health investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Bellus Health financial statements helps investors assess Bellus Health's valuation, profitability, and current liquidity needs.
There are currently sixty-three fundamental signals for Bellus Health that can be evaluated and compared over time across rivals. Make sure you validate Bellus Health's prevailing fundamentals against the performance from 2010 to 2022 and make sure the trends continue to evolve in the right direction.
Bellus Health Enterprise Value is comparatively stable at the moment as compared to the past year. Bellus Health reported Enterprise Value of 610.55 Million in 2021. Market Capitalization is likely to gain to about 680.4 M in 2022, whereas Free Cash Flow is likely to drop (62.8 M) in 2022.
  
Refresh
Check Bellus Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bellus main balance sheet or income statement drivers, such as Gross Profit of 16.4 K, Interest Expense of 52.1 K or Operating Expenses of 79.1 M, as well as many exotic indicators such as Asset Turnover of 9.0E-4, Book Value per Share of 3.83 or Current Ratio of 17.11. Bellus financial statements analysis is a perfect complement when working with Bellus Health Valuation or Volatility modules. It can also supplement various Bellus Health Technical models. Continue to the analysis of Bellus Health Correlation against competitors.

Bellus Health Revenues

16,421.05

Share

Bellus Health Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets334 M309.6 M93.6 M
Increasing
Slightly volatile
Cash and Equivalents161.9 M150.1 M37.1 M
Increasing
Slightly volatile
Investments79.3 M98.7 M33.1 M
Increasing
Slightly volatile
Investments Current79.3 M98.7 M33.1 M
Increasing
Slightly volatile
Property Plant and Equipment Net732.2 K853 K277.9 K
Increasing
Slightly volatile
Tax Assets1.1 M1.2 M622.9 K
Increasing
Slightly volatile
Trade and Non Trade Receivables459.6 K369 K1.2 M
Decreasing
Slightly volatile
Trade and Non Trade Payables18 M16.7 MM
Increasing
Slightly volatile
Total LiabilitiesM6.9 M3.4 M
Increasing
Slightly volatile
Shareholders Equity315.1 M292 M88.4 M
Increasing
Slightly volatile
Accumulated Other Comprehensive Income10.5 M10.7 M7.8 M
Increasing
Slightly volatile
Current Assets278.6 M258.2 M75.9 M
Increasing
Slightly volatile
Assets Non Current42.5 M51.4 M16.7 M
Increasing
Slightly volatile
Current Liabilities18.3 M16.9 M5.1 M
Increasing
Slightly volatile
Liabilities Non Current(11.2 M)(11 M)(1.4 M)
Decreasing
Slightly volatile
Tax Liabilities18.8 K18.9 K20.7 K
Decreasing
Slightly volatile
Total Debt939.8 K871 K237.8 K
Increasing
Slightly volatile
Debt Current212.4 K254 K81 K
Increasing
Slightly volatile
Debt Non Current603.8 K617 K387.5 K
Increasing
Slightly volatile
Shareholders Equity USD246.2 M228.1 M69.1 M
Increasing
Slightly volatile
Cash and Equivalents USD126.5 M117.2 M29 M
Increasing
Slightly volatile
Total Debt USD734.2 K680.5 K185.7 K
Increasing
Slightly volatile

Bellus Health Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues16.4 K16 K109 K
Decreasing
Slightly volatile
Selling General and Administrative Expense11.8 M14.3 M5.3 M
Increasing
Slightly volatile
Research and Development Expense64.5 M59.8 M16 M
Increasing
Slightly volatile
Operating Expenses79.1 M73.3 M21.2 M
Increasing
Slightly volatile
Interest Expense52.1 K55 K52.2 K
Decreasing
Slightly volatile
Income Tax Expense(183.8 K)(179.1 K)(36.3 K)
Decreasing
Slightly volatile
Weighted Average Shares84.5 M78.3 M22.1 M
Increasing
Slightly volatile
Revenues USD12.8 K12.5 K85.5 K
Decreasing
Slightly volatile
Gross Profit16.4 K16 K109 K
Decreasing
Slightly volatile

Bellus Health Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Cash Flow Business Acquisitions and Disposals(494.2 K)(481.5 K)2.3 M
Decreasing
Slightly volatile
Net Cash Flow Investment Acquisitions and Disposals(49.8 M)(48.5 M)(12.9 M)
Decreasing
Stable
Net Cash Flow from Financing226.4 M209.9 M53.4 M
Increasing
Slightly volatile
Issuance Purchase of Equity Shares227.1 M210.5 M53.6 M
Increasing
Slightly volatile
Net Cash Flow from Investing(49.5 M)(48.2 M)(11 M)
Decreasing
Stable
Effect of Exchange Rate Changes on Cash 837.3 K776 K132.1 K
Increasing
Slightly volatile
Net Cash Flow or Change in Cash and Cash Equivalents108.3 M100.4 M24.4 M
Increasing
Slightly volatile
Share Based Compensation5.1 M6.4 M1.8 M
Increasing
Slightly volatile
Depreciation Amortization and Accretion209.3 K193 K182.4 K
Increasing
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Gross Margin0.890.90.9842
Decreasing
Slightly volatile
Asset Turnover9.0E-49.0E-40.001
Decreasing
Slightly volatile
Sales per Share0.05170.05040.1931
Decreasing
Slightly volatile
Price to Sales Ratio54.4 K50.4 K10.5 K
Increasing
Slightly volatile
Price to Book Value2.982.7640.7071
Increasing
Slightly volatile
Debt to Equity Ratio0.03240.0210.0665
Decreasing
Slightly volatile
Current Ratio17.1115.23413.895
Increasing
Slightly volatile
Book Value per Share3.833.72842.0293
Decreasing
Slightly volatile
Tangible Assets Book Value per Share4.053.95245.3644
Decreasing
Slightly volatile

Bellus Health Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Capitalization680.4 M630.6 M129.7 M
Increasing
Slightly volatile
Enterprise Value658.8 M610.5 M153.7 M
Increasing
Slightly volatile
Invested Capital117.1 M143.4 M48.7 M
Increasing
Slightly volatile
Average Equity145.4 M159.4 M65 M
Increasing
Slightly volatile
Average Assets156.2 M172.2 M69.3 M
Increasing
Slightly volatile
Invested Capital Average94.9 M101.1 M44.8 M
Increasing
Slightly volatile
Tangible Asset Value334 M309.6 M93.6 M
Increasing
Slightly volatile
Working Capital260.3 M241.3 M70.8 M
Increasing
Slightly volatile

Bellus Fundamental Market Drivers

Forward Price Earnings-7.36
Shares Short Prior Month10.73M
Average Daily Volume Last 10 Day791.88k
Average Daily Volume In Three Month797.61k
Date Short Interest29th of April 2022
Fifty Day Average8.12
Two Hundred Day Average6.88

Bellus Upcoming Events

Upcoming Quarterly Report24th of February 2022
Next Financial Report9th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End24th of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

About Bellus Health Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Bellus Health income statement, its balance sheet, and the statement of cash flows. Bellus Health investors use historical funamental indicators, such as Bellus Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bellus Health investors may use each financial statement separately, they are all related. The changes in Bellus Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bellus Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bellus Health Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bellus Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Revenues16 K16.4 K
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough and other cough hypersensitivity indications. The company was incorporated in 1993 and is based in Laval, Canada. Bellus Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people.

Bellus Health Investors Sentiment

The influence of Bellus Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Bellus. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Bellus Health Implied Volatility

    
  117.69  
Bellus Health's implied volatility exposes the market's sentiment of Bellus Health stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bellus Health's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bellus Health stock will not fluctuate a lot when Bellus Health's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bellus Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bellus Health's short interest history, or implied volatility extrapolated from Bellus Health options trading.

Current Sentiment - BLU

Bellus Health Investor Sentiment

Greater number of Macroaxis users are currently bullish on Bellus Health. What is your opinion about investing in Bellus Health? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Continue to the analysis of Bellus Health Correlation against competitors. Note that the Bellus Health information on this page should be used as a complementary analysis to other Bellus Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Bellus Stock analysis

When running Bellus Health price analysis, check to measure Bellus Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bellus Health is operating at the current time. Most of Bellus Health's value examination focuses on studying past and present price action to predict the probability of Bellus Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bellus Health's price. Additionally, you may evaluate how the addition of Bellus Health to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Is Bellus Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bellus Health. If investors know Bellus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bellus Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
888.1 M
Return On Assets
-0.21
Return On Equity
-0.34
The market value of Bellus Health is measured differently than its book value, which is the value of Bellus that is recorded on the company's balance sheet. Investors also form their own opinion of Bellus Health's value that differs from its market value or its book value, called intrinsic value, which is Bellus Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bellus Health's market value can be influenced by many factors that don't directly affect Bellus Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bellus Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Bellus Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bellus Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.